Healthcare -
Biotechnology - NASDAQ - US
$ 14.52
-6.02 %
$ 1.1 B
Market Cap
-5.04
P/E
Price Target
Average
105.23%
Revenue Forecast
Estimate
73.08%
EBIT
Estimate
--23.12%
Net Income
Estimate
47.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Nurix Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for NRIX of $29.8 , with forecasts ranging from
a
low of
$17 to a high of $41 .
NRIX Lowest Price Target
Wall Street Target
17 USD
17.08%
NRIX Average Price Target
Wall Street Target
29.8 USD
105.23%
NRIX Highest Price Target
Wall Street Target
41 USD
182.37%
REVENUE FORECAST
Revenue Forecast Chart NRIX
EBIT FORECAST
EBIT Forecast Chart NRIX
NET INCOME FORECAST
Net Income Chart NRIX